CRAN/E | BOIN

BOIN

Bayesian Optimal INterval (BOIN) Design for Single-Agent and Drug- Combination Phase I Clinical Trials

Installation

About

The Bayesian optimal interval (BOIN) design is a novel phase I clinical trial design for finding the maximum tolerated dose (MTD). It can be used to design both single-agent and drug-combination trials. The BOIN design is motivated by the top priority and concern of clinicians when testing a new drug, which is to effectively treat patients and minimize the chance of exposing them to subtherapeutic or overly toxic doses. The prominent advantage of the BOIN design is that it achieves simplicity and superior performance at the same time. The BOIN design is algorithm-based and can be implemented in a simple way similar to the traditional 3+3 design. The BOIN design yields an average performance that is comparable to that of the continual reassessment method (CRM, one of the best model-based designs) in terms of selecting the MTD, but has a substantially lower risk of assigning patients to subtherapeutic or overly toxic doses. For tutorial, please check Yan et al. (2020) doi:10.18637/jss.v094.i13.

Citation BOIN citation info

Key Metrics

Version 2.7.2
Published 2021-01-19 1180 days ago
Needs compilation? no
License GPL-2
CRAN checks BOIN results

Downloads

Yesterday 5 -64%
Last 7 days 108 -27%
Last 30 days 559 -25%
Last 90 days 2.134 +22%
Last 365 days 7.669 +1%

Maintainer

Maintainer

Ying Yuan

yyuan@mdanderson.org

Authors

Ying Yuan
Suyu Liu

Material

Reference manual
Package source

In Views

ExperimentalDesign

macOS

r-release

arm64

r-oldrel

arm64

r-release

x86_64

r-oldrel

x86_64

Windows

r-devel

x86_64

r-release

x86_64

r-oldrel

x86_64

Old Sources

BOIN archive

Imports

Iso

Reverse Imports

escalation